{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 84,
  "pageCount": 239,
  "prevPage": 83,
  "nextPage": 85,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/84",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-84",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.615,
        "y": 0.345
      },
      "kind": "callout",
      "text": "Nevro claims that only 1.2% of Wave writer devices are explanted because of failure, and that only 3.7% are explanted overall",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a857a9f0-271d-45ef-a763-f1a38d840537",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.53,
        "w": 0.77,
        "x": 0.06,
        "y": 0.37
      },
      "kind": "image",
      "text": "Screenshot of Nevro investor slide showing 'Real World Results' and 'Lowest Explant Rate' claims.",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7cd89cb2-70da-4538-b223-088a8a02ac02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "explant rate: 3.7%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33c-bb0107e30fa0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.93,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Having run a sham pivotal study and with its sole product based on a flawed theory, reality dawned on Nevro as doctors and patients began to see the device fail. Nevro took the space by storm at launch in 2015, on the heels of exciting “data” that led doctors to try the device. Our research indicates that doctors soon began to notice problems with the device, which caused them to abandon Nevro in droves and explant (surgically remove) its stimulators. We begin by noting Nevro’s absurd claim of having the lowest explant rate in the industry.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50fe53d0-a94f-4b71-a76f-ae5ffebfd26e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.7,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Nevro Q1 2019 investor slides https://s24.q4cdn.com/932612397/files/doc_presentations/Nevro-IR-Presentation_Q12019_050919.pdf",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f045e8bc-3edd-478e-9ded-0b739de8f96d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.41,
        "x": 0.06,
        "y": 0.1
      },
      "kind": "title",
      "text": "6. A covered-up device failure and explants crisis",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3bbebf5-f906-4112-bdb9-a2df99ae1213",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.48,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71136403-15cf-4d82-9dcf-3ffb6085fe47",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "8ee3c7f5-5bcd-4e2f-9b37-0187bbd65211",
      "evidence": "The slide explicitly contrasts a corporate claim with research findings to expose a contradiction.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}